Renal Cancer - Results from #3300

Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma. September 25, 2019

Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery. September 25, 2019

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study. September 24, 2019

Ubiquitin-specific peptidase 46 (USP46) suppresses renal cell carcinoma tumorigenesis through AKT pathway inactivation. September 24, 2019

Human renal adipose tissue from normal and tumor kidney: its influence on renal cell carcinoma. September 24, 2019

The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results. September 23, 2019

Development and acceptability testing of a patient decision aid for individuals with localized renal masses considering surgical removal with partial or radical nephrectomy. September 23, 2019

Thiamine deficiency in a patient with recurrent renal cell carcinoma who developed weight loss with normal appetite and loss of energy soon after nivolumab treatment. September 22, 2019

Survival And Progression After Radical Nephrectomy In A Cohort Of Non-Metastatic Renal Cell Carcinoma Treated With Curative Intent. September 22, 2019

[Metastatic renal cell carcinoma to the pancreas: experience of surgical treatment]. September 22, 2019

Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer. September 21, 2019

Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration. September 21, 2019

[Robot-assisted laparoscopic partial nephrectomy]. September 21, 2019

CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma September 20, 2019

Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma. September 20, 2019

Chronic effects of repeated low dose cisplatin treatment in mouse kidneys and renal tubular cells. September 20, 2019

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-Deficient Renal Cell Carcinoma in 32 Patients. September 18, 2019

Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer. September 17, 2019

Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma. September 17, 2019

Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort. September 15, 2019

Page 166 of 456